Search
Now showing items 1-10 of 56
A randomized trial on hemodynamic optimization of cerebral perfusion after successful endovascular therapy in patients with acute ischemic stroke (HOPE)
(Karger, 2024-08-29)
[Abstract] Introduction: In patients with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion, optimal blood pressure (BP) management following endovascular treatment (EVT) has not yet been ...
Will neurological care change over the next 5 years due to the COVID-19 pandemic?: key informant consensus survey
(Elsevier, 2020-05-21)
[Abstract] Introduction. The COVID-19 pandemic will give rise to long-term changes in neurological care, which are not easily predictable.
Material and methods. A key informant survey was used to enquire about the changes ...
Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma
(Oxford University Press, 2021-03-16)
[Abstract] Haemorrhagic transformation is a complication of recombinant tissue-plasminogen activator treatment. The most severe form, parenchymal haematoma, can result in neurological deterioration, disability, and death. ...
Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
(Elsevier, 2019-08-11)
[Abstract]
Introduction: There is little control of cardiovascular (CV) risk factors in secondary prevention after an ischaemic stroke, in part due to a lack of adherence to treatment. The CV polypill may contribute ...
RP11-362K2.2:RP11-767I20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma: a GWAS meta-analysis
(MDPI, 2021-07-16)
[Abstract] Stroke is one of the most common causes of death and disability. Reperfusion therapies are the only treatment available during the acute phase of stroke. Due to recent clinical trials, these therapies may increase ...
Oral anticoagulation and risk of symptomatic hemorrhagic transformation in stroke patients treated with mechanical thrombectomy: data from the nordictus registry
(Frontiers, 2020-11-26)
[Abstract] Introduction: We aimed to evaluate if prior oral anticoagulation (OAC) and its type determines a greater risk of symptomatic hemorrhagic transformation in patients with acute ischemic stroke (AIS) subjected to ...
Characteristics of stroke units and stroke teams in Spain in 2018: Pre2Ictus project
(Elsevier, 2022-06-30)
[Abstract]
Introduction: The aim of this work is to describe the characteristics of stroke units and stroke teams in Spain.
Method: We performed a cross-sectional study based on an ad hoc questionnaire designed by ...
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain
(Sage, 2020-06-11)
[Abstract]
Background and purpose: Spain has been one of the countries heavily stricken by COVID-19. But this epidemic has not affected all regions equally. We analyzed the impact of the COVID-19 pandemic on hospital ...
A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment
(Elsevier, 2023-12-15)
[Abstract]
Background: Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the only pharmacologic intervention available in the ischemic stroke acute phase. This treatment is associated with an ...
Pre-existing cerebral small vessel disease limits early recovery in patients with acute lacunar infarct
(Elsevier, 2019-11)
[Abstract]
Background and purpose: To assess whether neuroimaging markers of chronic cerebral small vessel disease (cSVDm) influence early recovery after acute ischemic stroke (AIS).
Methods: Retrospective analysis ...